AI Skin Analysis Algorithm
Skin Lesion Analysis (e.g., early detection of melanoma)
Development/Clinical ValidationActive
Key Facts
Indication
Skin Lesion Analysis (e.g., early detection of melanoma)
Phase
Development/Clinical Validation
Status
Active
Company
About QRskin
Founded in 2018 and based in Munich, QRskin operates at the intersection of dermatology and digital health. The company is building an integrated platform that leverages artificial intelligence for skin lesion analysis and couples it with telemedicine capabilities to facilitate remote consultations. This approach targets the growing demand for accessible dermatological care and aims to reduce wait times for specialist appointments. As a private, early-stage company, QRskin is likely focused on technology validation, clinical studies, and initial market deployment in Germany and potentially the broader EU.
View full company profile